Changes of autoantibodies against oxidatively modified low density lipoproteins during long-term LDL-apheresis

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 12, Issue 6, 1999, Pages 413-417

  Turk, Zdenka ^a,c   Mrzljak, V ^a   Turk, N ^b   Metelko, Z ^a  

^a University of Zagreb   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c KBC Zagreb   (Croatia)

Author keywords

Antibodies to oxidised LDL; Hyperlipidaemia; LDL apheresis

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN B; AUTOANTIBODY; BIOLOGICAL MARKER; CHOLESTEROL; IMMUNOGLOBULIN G; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; MEVINOLIN; TRIACYLGLYCEROL;

ADULT; ANTIBODY TITER; APHERESIS; ARTICLE; ATHEROSCLEROSIS; BIOCHEMISTRY; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HEAT SENSATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; HYPOTENSION; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; LONG TERM CARE; OXIDATION; PRIORITY JOURNAL; PROTEIN MODIFICATION; SIDE EFFECT; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; VERTIGO; XANTHOMA;

ADULT; AUTOANTIBODIES; BLOOD COMPONENT REMOVAL; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; FEMALE; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; LIPOPROTEINS, LDL; TRIGLYCERIDES;

EID: 0033382996     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Steinberg D.: Low density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem. 272: 20963-20966, 1997.
2. Craig W.Y.: Autoantibodies against oxidized low density lipoprotein: a review of clinical findings and assay methodology. J. Clin. Lab. Anal. 9: 70-74, 1995.
3. Salonen J.T., Yla-Herttuala S., Yamamoto R., Butler S., Korpela H., Salonen R., Nyyssonen K., Palinski W., Witztum J.L.: Autoantibody against oxidized-LDL and progression of carotid atherosclerosis. Lancet 339: 883-886, 1992.
4. Maggi E., Marchesi E., Ravetta V., Falashi F., Finardi G., Bellomo G.: Low-density lipoprotein oxidation in essential hypertension. J. Hypertens. 11: 1103-1111, 1993.
5. Festa A., Kopp H.P., Schernthaner G., Menzel E.J.: Autoantibodies to oxidized low density lipoproteins in IDDM are inversely related to metabolic control and microvascular complications. Diabetologia 41: 350-356, 1998.
6. Maggi E., Bellazzi R., Falaschi F., Frattoni A., Perani G., Finardi G., Gazo A., Nai M., Romanini D., Bellomo G.: Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis? Kidney Int. 45: 876-883, 1994.
7. Chiesa R., Melissano G., Castellano R., Astore D., Marone E.M., Grossi A., Maggi E., Finardi G., Casasco A., Bellomo G.: In search of biological markers of high-risk carotid artery atherosclerotic plaque-enhanced LDL oxidation. Ann. Vasc. Surg. 12: 1-9, 1998.
8. Gordon B.R., Saal S.D.: Advances in LDL-apheresis for the treatment of severe hypercholesterolemia. Curr. Opin. Lipidol. 5: 69-73, 1994.
9. Seidel D.: The H.E.L.P. system: an efficient and safe method for plasma therapy in the treatment of severe hypercholesterolemia. Isr. J. Med. Sci. 32: 407-413, 1996.
10. Thompson G.R., Maher V.M.G., Matthews S., Kitano Y., Neuwirth C., Shortt M.B., Davies G., Rees A., Mir A., Prescott R.J., deFeyter P., Henderson A.: Familial hypercholesterolaemia regression study: a randomised trial of low-density-lipoprotein apheresis. Lancet 345: 811-816, 1995.
11. Lane D.M., McConathy W.J., Laughlin L.O., Comp P.C., von Albertini B., Bricker L.A., Kozlovskis P., Lees R.S., Dorrier C.: Selective removal of plasma low density lipoprotein with the HELP system: biweekly versus weekly therapy. Atherosclerosis 114: 203-211, 1995.
12. Leitinger N., Pirich C., Blazek I., Endler G., Sinzinger H.: Decreased susceptibility of low-density lipoproteins to in vitro oxidation after dextran-sulfate LDL-apheresis treatment. Atherosclerosis 126: 305-312, 1996.
13. Ylä-Herttuala S., Palinski W., Picard S., Butler S., Steinberg D., Witztum J.L.: Rabbit and human atherosclerotic lesions containing IgG that recognizes epitopes of oxidized-LDL. Arterioscler. Thromb. 14: 32-40, 1994.